Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC.AGIO · Entity 4499 | Director | June 18, 2026 | June 23, 2026 |
| JOHNSON & JOHNSONJNJ · Entity 2722 | VP, Human Resources | December 31, 2009 | January 05, 2010 |
| Prime Medicine, Inc.PRME · Entity 5281 | Director | June 05, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGIOS PHARMACEUTICALS, INC.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 10,284 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Exercise / conversion · Acquired 2,816 · Balance 10,284 |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-18 · Exercise / conversion · Disposed 2,816 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 2,927 |
Reported balance
After 2026-06-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-18 · Grant · Acquired 2,927 · Balance 2,927 F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3: The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested. |
| Stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.16 · Expires 2036-06-18 | Direct | 14,950 |
Reported balance
After 2026-06-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-18 · Grant · Acquired 14,950 · Balance 14,950 F4: These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027. |
| Common stockSEC Table I · non-derivative | IndirectBy Foster Family Revocable Trust | 2,200 |
Reported balance
Holding disclosure · report date 2026-06-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,200 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F3: The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F4: These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027.
JOHNSON & JOHNSON
Report date December 31, 2009 · Filed January 05, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | IndirectJohnson & Johnson Stock Fund under the 401(k) Savings Plan | 1,181 |
Reported balance
After 2009-12-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2009-12-31 · Other · Acquired 34 · Balance 1,181 F2: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2009). |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,998 |
Reported balance
After 2009-12-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-12-31 · Grant · Acquired 45 · Balance 5,998 F4: Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2009 at $64.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. |
| Common StockSEC Table I · non-derivative | Direct | 4,583 |
Reported balance
Holding disclosure · report date 2009-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,583 F1: Includes 819 shares held under Issuer's Dividend Reinvestment Program. |
| CommonSEC Table I · non-derivative | IndirectESOP under the 401(k) Savings Plan | 33 |
Reported balance
Holding disclosure · report date 2009-12-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 33 F3: Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2009). |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 819 shares held under Issuer's Dividend Reinvestment Program.
F2: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2009).
F3: Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2009).
F4: Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2009 at $64.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time.
Prime Medicine, Inc.
Report date June 05, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.06 · Expires 2036-06-05 | Direct | 75,000 |
Reported balance
After 2026-06-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 75,000 · Balance 75,000 F1: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2027 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2027 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2008 Filed Feb 13, 2008 22:39 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 26 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-08-000038 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 775 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (01/31/2008). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (01/31/2008). Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 22:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-08-000005 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,612 Underlying: Common Stock · 16 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2007 at $67.48 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2007 at $67.48 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2007 at $67.48 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 22:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 5 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-08-000005 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 749 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (12/31/2007). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (12/31/2007). Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 20:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 4 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000124 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 744 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (09/28/2007). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (09/28/2007). Read SEC document |
| June 29, 2007 Filed Jul 2, 2007 22:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-07-000094 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,580 Underlying: Common Stock · 18 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 29 2007 at $61.52 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 29 2007 at $61.52 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 29 2007 at $61.52 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| June 29, 2007 Filed Jul 2, 2007 22:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 119 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000094 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 740 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (06/29/2007). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (06/29/2007). Read SEC document |
| June 29, 2007 Filed Oct 2, 2007 20:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-07-000124 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,596 Underlying: Common Stock · 16 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 28, 2007 at $65.55 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 28, 2007 at $65.55 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 28, 2007 at $65.55 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| March 30, 2007 Filed Mar 30, 2007 20:12 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-07-000065 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,562 Underlying: Common Stock · 15 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 30, 2007 at $60.25 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 30, 2007 at $60.25 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 30, 2007 at $60.25 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| February 28, 2007 Filed Mar 30, 2007 20:12 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 28 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000065 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 621 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (02/28/2007). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (02/28/2007). Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 23:30 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPhantom Stock Units · Derivative | 1,259 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-07-000043 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,547 Underlying: Common Stock · 1,259 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 16, 2007 at $65.49 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 16, 2007 at $65.49 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 16, 2007 at $65.49 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| February 12, 2007 Filed Feb 15, 2007 22:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,715 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-07-000023 · edgar.xml · derivative · entry 5 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,715 Underlying: Common Stock · 5,715 shares Expires not disclosed F6 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock. F7 · derivative.expiration_date: The Restricted Share Units vest three years after date of grant. Read SEC document |
| February 12, 2007 Filed Feb 15, 2007 22:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Option (Right to Buy) · Derivative | 68,577 | $0.00 Strike: $65.62 | $0.00 |
DisclosureSEC source: 0000200406-07-000023 · edgar.xml · derivative · entry 4 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,577 Underlying: Common Stock · 68,577 shares Expires 2017-02-10 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| January 31, 2007 Filed Feb 15, 2007 22:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 24 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000023 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 593 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (01/31/2007). Read SEC document |
| December 29, 2006 Filed Jan 4, 2007 22:24 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-07-000005 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,288 Underlying: Common Stock · 7 shares Expires not disclosed F4 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 29, 2006 at $66.23 per share are to be settled in cash upon the Reporting Person's Retirement. F5 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 29, 2006 at $66.23 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 29, 2006 at $66.23 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| December 29, 2006 Filed Jan 4, 2007 22:24 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 3 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000005 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 569 F3 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (12/29/2006). Read SEC document |
| December 19, 2006 Filed Jan 4, 2007 22:24 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon | 6 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000005 · edgar.xml · nonDerivative · entry 1 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631 F1 · price: Gift F2 · balance_after: Includes shares acquired under Issuer's Dividend Reinvestment Program. Read SEC document |
| September 29, 2006 Filed Oct 3, 2006 19:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-06-000127 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,281 Underlying: Common Stock · 8 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 29, 2006 at $64.93 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 29, 2006 at $64.93 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 29, 2006 at $64.93 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| September 29, 2006 Filed Oct 3, 2006 19:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 5 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-06-000127 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 566 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (09/29/2006). Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 19:02 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-06-000101 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,273 Underlying: Common Stock · 8 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2006 at $59.63 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2006 at $59.63 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2006 at $59.63 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 19:02 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 97 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-06-000101 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 561 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (06/30/2006). Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 14:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-06-000074 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265 Underlying: Common Stock · 7 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2006 at $59.42 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2006 at $59.42 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2006 at $59.42 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 14:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 53 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-06-000074 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 464 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (03/31/2006). Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPhantom Stock Units · Derivative | 1,258 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-06-000050 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,258 Underlying: Common Stock · 1,258 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 17, 2006 at $59.01 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 17, 2006 at $59.01 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 17, 2006 at $59.01 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| February 13, 2006 Filed Feb 15, 2006 17:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,999 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-06-000039 · edgar.xml · derivative · entry 4 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,999 Underlying: Common Stock · 5,999 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one share of Company common stock. F5 · derivative.expiration_date: The restricted share units vest three years after date of grant. Read SEC document |
| February 13, 2006 Filed Feb 15, 2006 17:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Option (Right to Buy) · Derivative | 71,992 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0000200406-06-000039 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,992 Underlying: Common Stock · 71,992 shares Expires 2016-02-12 F3 · security: Awarded under Issuer's Long-Term Incentive Plan Read SEC document |
| January 31, 2006 Filed Feb 15, 2006 17:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 149 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-06-000039 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 411 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (01/31/2006). Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 17:42 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | Not disclosed Strike: $66.18 | Not disclosed |
DisclosureSEC source: 0000200406-05-000020 · edgar.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common · 40,000 shares Expires 2015-02-13 F3 · security: Awarded under Issuer's Stock Option Plan. F3 · price: Awarded under Issuer's Stock Option Plan. Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 17:42 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon | 369 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-05-000020 · edgar.xml · nonDerivative · entry 1 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610 F1 · price: Awarded under Issuer's Stock Compensation Plan. Read SEC document |
| January 31, 2005 Filed Feb 16, 2005 17:42 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 27 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-05-000020 · edgar.xml · nonDerivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) and ESOP Savings Plans Disclosed balance after: 262 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (01/31/2005). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.